Iohexol Ge Healthcare (Iohexol)

Iohexol contains iodine atoms that absorb X‑ray photons. When injected, it increases the radiodensity of the extracellular fluid and vascular spaces, creating a contrast difference between structures and allowing clearer images in X‑ray‑based studies.

The dose of Iohexol is determined by the prescribing clinician based on the specific imaging study, patient size, renal function and the required level of contrast. No fixed regimen is provided; the prescriber tailors the volume to each case.

Safety data for Iohexol during pregnancy and lactation are limited. It should only be used when the diagnostic benefit outweighs potential risks, and the decision must be made by the treating physician in consultation with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Iohexol is a non‑ionic, low‑osmolality iodinated contrast medium, offering a favorable safety profile compared with older high‑osmolality agents. Compared with other low‑osmolality agents such as iopamidol, Iohexol provides similar image quality while maintaining comparable rates of adverse reactions.

Iohexol should be stored at ambient temperature, below 25 °C, in its original container. Protect the solution from direct sunlight, moisture and extreme temperatures. Do not freeze or shake the vial before use.

Iohexol is supplied as a sterile solution for injection and may be administered intra‑arterially, intravenously or intrathecally, depending on the imaging procedure. Administration is performed by qualified healthcare professionals under controlled conditions.

The most serious risks include severe allergic reactions such as anaphylaxis, contrast‑induced nephropathy leading to acute renal failure, and cardiovascular events like severe hypotension or arrhythmias. Immediate medical attention is required if any of these occur.

Iohexol is contraindicated in patients with a known hypersensitivity to iodine‑containing contrast media, those with severe renal impairment where alternative imaging is possible, and individuals who have experienced prior severe reactions to iodinated contrast agents.